Brain Injury Study Hopes to Improve Patient Recovery

By Grant Law Office on October 14, 2014

The National Institutes of Health is currently conducting a new study on a drug called tranexamic acid that may help improve the chances of recovery after a traumatic brain injury accident. The drug has been approved by the Food and Drug Administration.

As part of the study, at least 10 trauma centers throughout North America will participate by randomly assigning qualifying patients to one of three test groups. One group of patients will be given the drug once at the scene of the injury accident, such as a car crash or slip and fall, and then again at the hospital. The second group will receive the drug at the scene of the incident, followed by salt water once at the hospital. The third group will receive salt water both at the scene and at the hospital.

The study intends to test the effects of tranexamic acid on at least 100 patients and will track their progress over a period of six months after leaving the hospital.

Tranexamic acid is typically used to prevent excessive blood loss during medical procedures. Traumatic brain injuries have a high potential for causing a wide range of physical, emotional, and cognitive disabilities, and it is hoped that by reducing bleeding in the brain, patients will be able to recover more fully.

As one of the most potentially devastating injuries an individual can suffer, the attorneys at Grant Law Offices, P.C. believe it is important to stay up-to-date on brain injury treatments. If you are the victim of a brain injury accident, contact an experienced Atlanta personal injury attorney to understand your rights.